Search research articles
Contact Us
Filters
Showing results (91-100 of 98) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 98 results.
Epidemiology and Infection
|
October 17, 2013
Yersinia enterocolitica infections associated with improperly pasteurized milk products: southwest Pennsylvania, March-August, 2011
A H Longenberger, M P Gronostaj, G Y Yee, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 23, 1999
Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPI
D W Snyder, N J Bach, R D Dillard, et al.
Frontiers in Pharmacology
|
August 5, 2022
Comparative Pharmacokinetics and Local Tolerance of Tenofovir Alafenamide (TAF) From Subcutaneous Implant in Rabbits, Dogs, and Macaques
G J Gatto, A Krovi, L Li, et al.
Journal of Medicinal Chemistry
|
December 20, 1996
Indole inhibitors of human nonpancreatic secretory phospholipase A2. 2. Indole-3-acetamides with additional functionality
R D Dillard, N J Bach, S E Draheim, et al.
Journal of Medicinal Chemistry
|
December 20, 1996
Indole inhibitors of human nonpancreatic secretory phospholipase A2. 3. Indole-3-glyoxamides
S E Draheim, N J Bach, R D Dillard, et al.
Journal of Medicinal Chemistry
|
December 20, 1996
Indole inhibitors of human nonpancreatic secretory phospholipase A2. 1. Indole-3-acetamides
R D Dillard, N J Bach, S E Draheim, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 14, 1999
Dibasic benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors: 2. Sidechain optimization and demonstration of in vivo efficacy
M Zhang, D L Bailey, J A Bastian, et al.
Journal of Medicinal Chemistry
|
February 26, 2000
Diamino benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors. 5. Potency, efficacy, and pharmacokinetic properties of modified C-3 side chain derivatives
D J Sall, D L Bailey, J A Bastian, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 98) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 98 results.
Epidemiology and Infection
|
October 17, 2013
Yersinia enterocolitica infections associated with improperly pasteurized milk products: southwest Pennsylvania, March-August, 2011
A H Longenberger, M P Gronostaj, G Y Yee, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 23, 1999
Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPI
D W Snyder, N J Bach, R D Dillard, et al.
Frontiers in Pharmacology
|
August 5, 2022
Comparative Pharmacokinetics and Local Tolerance of Tenofovir Alafenamide (TAF) From Subcutaneous Implant in Rabbits, Dogs, and Macaques
G J Gatto, A Krovi, L Li, et al.
Journal of Medicinal Chemistry
|
December 20, 1996
Indole inhibitors of human nonpancreatic secretory phospholipase A2. 2. Indole-3-acetamides with additional functionality
R D Dillard, N J Bach, S E Draheim, et al.
Journal of Medicinal Chemistry
|
December 20, 1996
Indole inhibitors of human nonpancreatic secretory phospholipase A2. 3. Indole-3-glyoxamides
S E Draheim, N J Bach, R D Dillard, et al.
Journal of Medicinal Chemistry
|
December 20, 1996
Indole inhibitors of human nonpancreatic secretory phospholipase A2. 1. Indole-3-acetamides
R D Dillard, N J Bach, S E Draheim, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 14, 1999
Dibasic benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors: 2. Sidechain optimization and demonstration of in vivo efficacy
M Zhang, D L Bailey, J A Bastian, et al.
Journal of Medicinal Chemistry
|
February 26, 2000
Diamino benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors. 5. Potency, efficacy, and pharmacokinetic properties of modified C-3 side chain derivatives
D J Sall, D L Bailey, J A Bastian, et al.
Page
of 10